Haemostatic Studies in Carbohydrate-deficient Glycoprotein Syndrome Type I

Summary

CDG syndrome (CDGS) type I is the most frequent form of a group of metabolic disorders characterised by a defect of the carbohydrate moiety of glycoproteins. A large number of plasma glycoproteins, including clotting factors and inhibitors, are decreased and stroke-like episodes have been described in about half of the reported patients. We studied blood coagulation factors, inhibitors and D-dimer plasma levels in four subjects, aged 12-23 years, with CDGS type I. Factors VIII, XI, antithrombin III activity, antigen plasma levels of antithrombin III, free protein S and protein C were decreased whereas protein C as activity was normal. In addition two patients had reduction of factors II, V, VII, IX, X reflecting the phenotypic heterogeneity associated with CDGS type I. D-dimer plasma concentrations were elevated in all subjects. The hypercoagulable state as consequence of the combined deficiencies of coagulation inhibitors could contribute to the stroke-like phenomena in CDGS type I.

• References

• 1 Jaeken J, Carchon H. The carbohydrate deficient glycoprotein syndromes: An overview. J Inher Metab Dis 1993; 16: 813-820
• 2 Jaeken J, Carchon H, Stibler H. The carbohydrate-deficient glycoprotein syndromes: pre-Golgi and Golgi disorders?. Glycobiology 1993; 3: 423-428
• 3 Stibler H, Stephani U, Kutsch U. Carbohydrate-deficient glycoprotein syn-drome-A fourth subtype. Neuropediatrics 1995; 26: 235-237
• 4 Van Schaftingen E, Jaeken J. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett 1995; 377: 318-320
• 5 Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G. Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. Arch Dis Child 1994; 71: 123-127
• 6 Martinsson T, Bursell C, Stibler H, Kristiansson B, Skovby F, Jaeken J, Blennow G, Stromme P, Hanefeld F, Wahlstrom J. Linkage of a locus for carbohydrate-deficient glycoprotein syndrome type I (CDG1) to chromosome 16 p, and linkage disequilibrium to microsatellite marker D16S406. Hum Mol Genet 1994; 3: 2037-2042
• 7 Jaeken J, Stibler H, Hagberg B. The carbohydrate-deficient glycoprotein syndrome: a new inherited multisystemic disease with severe nervous system involvement. Acta Paediatr Scand Suppl 1991; 375 (monograph)
• 8 Stibler H, Blennow G, Kristiansson B, Lindehammer H, Hagberg B. Carbohydrate-deficient glycoprotein syndrome: clinical expression in adults with a new metabolic disease. J Neurol Neurosurg Psychiatry 1994; 57: 552-556
• 9 Van Geet C, Jaeken J. A unique pattern of coagulation abnormalities in carbohydrate-deficient glycoprotein syndrome. Pediatr Res 1993; 33: 540-541
• 10 Okamoto N, Wada Y, Kobayashi M, Otani K, Tagawa T, Futagi Y, Imayoshi Y, Hayashi A, Shimizu A, Kato Y. Decreased blood coagulation activities in carbohydrate-deficient glycoprotein syndrome. J Inher Metab Dis 1993; 16: 435-440
• 11 Iijima K, Murakami F, Nakamura K, Ikawa S, Yuasa I, Motosumi H, Ohno K, Tashita K. Hemostatic studies in patients with carbohydrate-deficient glycoprotein syndrome. Thromb Res 1994; 76: 193-198
• 12 Fiumara A, Barone R, Buttitta P, Di Pietro M, Scuderi A, Nigro F, Jaeken J. Carbohydrate deficient glycoprotein syndrome type I: Ophthalmic aspects in four Sicilian patients. Br J Ophthalmol 1994; 78: 845-846
• 13 Mancini G, Carbonara A. Immunochemical quantitation of antigens by single radial immunodiffusion. J Immunochem 1965; 2: 235-239
• 14 Alving BA, Barr CF, Johansen LE, Tang DB. Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper time for verification of lupus anticoagulans. Thromb Haemost 1992; 67: 672-678
• 15 Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci A, Inzitari D. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 1991; 23: 189-193
• 16 Grinnel BW, Walls JD, Gerlitz B. Glycosilation of human protein C affects its secretion, processing, functional activities and activation by thrombin. J Biol Chem 1991; 226: 9778-9785
• 17 Martinez HR, Rangel-Guerra RA, Marfil LJ. Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults. Stroke 1993; 24: 19-25
• 18 Van Kuijck MAP, Rotteveel JJ, Van Oostrom CG, Novakova I. Neurological complications in children with Protein C deficiency. Neuropediatrics 1994; 25: 16-19
• 19 Bauer KA, Broekmans AW, Bertina RM, Conard J, Horellou MH, Samana MM, Rosenberg RD. Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency. Blood 1988; 72: 343-350
• 20 Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood 1987; 70: 343-350